Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Patient-centric Drug Discovery
 Real World Evidence
 Extrusion-based Drug Implants
Oct 2017 e-Newsletter Archives    |    Advertise
Turkish Cargo
News
Sanofi invests €170 million in new vaccine...
Astellas and Universal Cells, Inc. Announce a...
Xynomic Pharma Acquires Global Rights of...
 
Press Releases
Vetter to expand its Secondary Packaging...
Biogen and Eisai Expand Existing Collaboration...
Daiichi Sankyo and Glycotope Announce...
 
Events
31 -01 Oct 2017
World Biosimilar Congress 2017
02 -03 Nov 2017
Patient Summit USA
06 -08 Nov 2017
BIO-Europe 2017
09 -11 Nov 2017
Life Sciences Ingredients
Articles
  Emerging Directions in R&D of Drug Discovery and Development
Subhadra Dravida A Soorneedi Transcell Biologics
Delivering patient relevant healthcare and patient centric drug discovery and innovation based approach globally is the new and emerging requirement. It means, the very starting material, knowledge and data...
  Use of Real World Evidence
Christopher-Paul Milne, Tufts Center for the Study of Drug Development, Tufts University Medical School
Real World Evidence (RWE) can be used to inform decisions throughout the life cycle of a drug, from development through post-approval. Across Asia, many countries have begun incorporating real world evidence...
Vetter
Techno Trends
 New Drug Development Workflow Designed for Extrusion-Based...
 Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough...
Projects
 ImmunoPrecise Antibodies Announces New Antibody Production...
 Nitto Denko Avecia Announces Opening of Manufacturing Expansion...
Vetter
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555